This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Han, S. Articles by Ramesh, V. Search for Related Content PubMed PubMed Citation Articles by Han, S. Articles by Ramesh, V.

Phosphorylation of Tuberin as a Novel Mechanism for Somatic Inactivation of the Tuberous Sclerosis Complex Proteins in Brain Lesions

¹ Molecular Neurogenetics Unit, ² Molecular Neuro-Oncology, and ³ Department of Neurology, Harvard Medical School/Massachusetts General Hospital, Charlestown, Massachusetts

Tuberous sclerosis complex is caused by mutations in tumor suppressor genes TSC1 or TSC2 and is characterized by the presence of hamartomas in many organs. Although tuberous sclerosis complex is a tumor suppressor gene syndrome with classic "second hits" detectable in renal tumors, conventional genetic analysis has not revealed somatic inactivation of the second allele in the majority of human brain lesions. We demonstrate a novel mechanism of post-translational inactivation of the TSC2 protein, tuberin, by physiologically inappropriate phosphorylation, which is specific to tuberous sclerosis complex-associated brain lesions. Additional analysis shows that tissue specificity is due to abnormal activation of the Akt and mitogen-activated protein kinase pathways in brain but not in renal tumors. These results have widespread implications for understanding the tissue specificity of tumor suppressor gene phenotypes.

This article has been cited by other articles:

				M. F. James, S. Han, C. Polizzano, S. R. Plotkin, B. D. Manning, A. O. Stemmer-Rachamimov, J. F. Gusella, and V. Ramesh NF2/Merlin Is a Novel Negative Regulator of mTOR Complex 1, and Activation of mTORC1 Is Associated with Meningioma and Schwannoma Growth Mol. Cell. Biol., August 1, 2009; 29(15): 4250 - 4261. [Abstract] [Full Text] [PDF]

				S. Han, C. Polizzano, G. P. Nielsen, F. J. Hornicek, A. E. Rosenberg, and V. Ramesh Aberrant Hyperactivation of Akt and Mammalian Target of Rapamycin Complex 1 Signaling in Sporadic Chordomas Clin. Cancer Res., March 15, 2009; 15(6): 1940 - 1946. [Abstract] [Full Text] [PDF]

				V. P. Krymskaya Smooth Muscle like Cells in Pulmonary Lymphangioleiomyomatosis Proceedings of the ATS, January 1, 2008; 5(1): 119 - 126. [Abstract] [Full Text] [PDF]

				L. Ma, J. Teruya-Feldstein, P. Bonner, R. Bernardi, D. N. Franz, D. Witte, C. Cordon-Cardo, and P. P. Pandolfi Identification of S664 TSC2 Phosphorylation as a Marker for Extracellular Signal-Regulated Kinase Mediated mTOR Activation in Tuberous Sclerosis and Human Cancer Cancer Res., August 1, 2007; 67(15): 7106 - 7112. [Abstract] [Full Text] [PDF]

				L. Meikle, D. M. Talos, H. Onda, K. Pollizzi, A. Rotenberg, M. Sahin, F. E. Jensen, and D. J. Kwiatkowski A Mouse Model of Tuberous Sclerosis: Neuronal Loss of Tsc1 Causes Dysplastic and Ectopic Neurons, Reduced Myelination, Seizure Activity, and Limited Survival J. Neurosci., May 23, 2007; 27(21): 5546 - 5558. [Abstract] [Full Text] [PDF]

				K Ridler, J Suckling, N. Higgins, P. de Vries, C. Stephenson, P. Bolton, and E. Bullmore Neuroanatomical Correlates of Memory Deficits in Tuberous Sclerosis Complex Cereb Cortex, February 1, 2007; 17(2): 261 - 271. [Abstract] [Full Text] [PDF]

				J. Yu and E. P. Henske Estrogen-Induced Activation of Mammalian Target of Rapamycin Is Mediated via Tuberin and the Small GTPase Ras Homologue Enriched in Brain Cancer Res., October 1, 2006; 66(19): 9461 - 9466. [Abstract] [Full Text] [PDF]

				C. Wilson, C. Bonnet, C. Guy, S. Idziaszczyk, J. Colley, V. Humphreys, J. Maynard, J. R. Sampson, and J. P. Cheadle Tsc1 Haploinsufficiency without Mammalian Target of Rapamycin Activation Is Sufficient for Renal Cyst Formation in Tsc1+/- Mice Cancer Res., August 15, 2006; 66(16): 7934 - 7938. [Abstract] [Full Text] [PDF]

				M. J. Riemenschneider, R. A. Betensky, S. M. Pasedag, and D. N. Louis AKT Activation in Human Glioblastomas Enhances Proliferation via TSC2 and S6 Kinase Signaling Cancer Res., June 1, 2006; 66(11): 5618 - 5623. [Abstract] [Full Text] [PDF]

				S. J. Zacharek, Y. Xiong, and S. D. Shumway Negative Regulation of TSC1-TSC2 by Mammalian D-Type Cyclins Cancer Res., December 15, 2005; 65(24): 11354 - 11360. [Abstract] [Full Text] [PDF]

				D. J. Kwiatkowski and B. D. Manning Tuberous sclerosis: a GAP at the crossroads of multiple signaling pathways Hum. Mol. Genet., October 15, 2005; 14(suppl_2): R251 - R258. [Abstract] [Full Text] [PDF]

				T. Ichikawa, A. Wakisaka, S. Daido, S. Takao, T. Tamiya, I. Date, S. Koizumi, and Y. Niida A Case of Solitary Subependymal Giant Cell Astrocytoma: Two Somatic Hits of TSC2 in the Tumor, without Evidence of Somatic Mosaicism J. Mol. Diagn., October 1, 2005; 7(4): 544 - 549. [Abstract] [Full Text] [PDF]

				S. Goh, W. Butler, and E. A. Thiele Subependymal giant cell tumors in tuberous sclerosis complex Neurology, October 26, 2004; 63(8): 1457 - 1461. [Abstract] [Full Text] [PDF]

				P. P. Roux, B. A. Ballif, R. Anjum, S. P. Gygi, and J. Blenis Tumor-promoting phorbol esters and activated Ras inactivate the tuberous sclerosis tumor suppressor complex via p90 ribosomal S6 kinase PNAS, September 14, 2004; 101(37): 13489 - 13494. [Abstract] [Full Text] [PDF]

				P. B. Crino Molecular Pathogenesis of Tuber Formation in Tuberous Sclerosis Complex J Child Neurol, September 1, 2004; 19(9): 716 - 725. [Abstract] [PDF]